Annual EBITDA
$8.26B$1.04B-11.20%
Summary
- Current Value
- As of today, ELV annual EBITDA is $8.26B, down -11.20% on
- Historical Performance
- ELV annual EBITDA is down -10.99% over the past 3 years, up +11.69% over the past 5 years
- All-Time High Comparison
- ELV annual EBITDA is currently -12.73% below its historical high of $9.46B set on
- 3-Year Low Comparison
- ELV annual EBITDA is at its 3-year low
- Sector Comparison
- ELV annual EBITDA is higher than 98.29% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $8.26B | -11.2% | -11.0% | +11.7% | +66.6% | |
| Quarterly EBITDA | $2.66B | -16.1% | -13.7% | +8.1% | +68.5% | |
| TTM EBITDA | $7.74B | -15.8% | -20.1% | +3.4% | +53.1% | |
| Price | $372.68 | -9.1% | -18.4% | -4.8% | +382.8% | |
| PE Ratio | 15.86 | -0.9% | -12.4% | -24.3% | +51.9% | |
| Annual Revenue | $199.13B | +12.6% | +27.2% | +63.4% | +238.4% | |
| Annual EPS | $25.21 | -1.8% | +3.9% | +40.2% | +263.3% | |
| $6.71B | -15.1% | -11.7% | +7.6% | +54.1% | ||
| Annual Net Income | $5.66B | -5.2% | -3.9% | +23.8% | +96.1% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $9.46B | -12.7% | |
| 5Y | $9.46B | -12.7% | |
| All | $9.46B | -12.7% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $8.26B | at low | |
| 5Y | $7.39B | N/A | +11.7% |
| All | $964.60M | +755.9% |
EBITDA History
FAQ
What is the current annual EBITDA of ELV?
As of today, ELV annual EBITDA is $8.26B
What is 1-year change in ELV annual EBITDA?
ELV annual EBITDA is down -11.20% year-over-year
What is 3-year change in ELV annual EBITDA?
ELV annual EBITDA is down -10.99% over the past 3 years
How far is ELV annual EBITDA from its all-time high?
ELV annual EBITDA is currently -12.73% below its historical high of $9.46B set on December 31, 2023
How does ELV annual EBITDA rank versus sector peers?
ELV annual EBITDA is higher than 98.29% of companies in Healthcare sector
When is ELV next annual earnings release?
As of today, the next annual earnings release for ELV has not been scheduled
Quarterly EBITDA
$2.66B$2.04B+328.02%
Summary
- Current Value
- As of today, ELV quarterly EBITDA is $2.66B, up +328.02% on
- Historical Performance
- ELV quarterly EBITDA is down -16.15% year-over-year, down -13.73% over the past 3 years
- All-Time High Comparison
- ELV quarterly EBITDA is currently -40.63% below its historical high of $4.48B set on
- 3-Year Low Comparison
- ELV quarterly EBITDA is +328.02% above its 3-year low of $621.00M reached on
- Sector Comparison
- ELV quarterly EBITDA is higher than 98.62% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $2.66B | +328.0% | -16.1% | -13.7% | +8.1% | |
| Annual EBITDA | $8.26B | – | -11.2% | -11.0% | +11.7% | |
| TTM EBITDA | $7.74B | -6.2% | -15.8% | -20.1% | +3.4% | |
| Price | $372.68 | +9.4% | -9.1% | -18.4% | -4.8% | |
| PE Ratio | 15.86 | +17.0% | -0.9% | -12.4% | -24.3% | |
| Quarterly Revenue | $50.18B | +0.9% | +2.6% | +19.0% | +55.0% | |
| Quarterly EPS | $8.00 | +224.5% | -16.7% | -3.5% | +19.3% | |
| $2.30B | +971.6% | -17.6% | -12.0% | +5.9% | ||
| Quarterly Net Income | $1.76B | +222.3% | -19.4% | -12.2% | +5.6% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $3.17B | N/A | -16.1% |
| 3Y | $3.32B | -20.0% | |
| 5Y | $3.32B | -20.0% | |
| All | $4.48B | -40.6% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $621.00M | +328.0% | |
| 3Y | $621.00M | +328.0% | |
| 5Y | $621.00M | +328.0% | |
| All | $215.20M | +1135.1% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of ELV?
As of today, ELV quarterly EBITDA is $2.66B
What is ELV quarterly EBITDA most recent change?
ELV quarterly EBITDA was up +328.02% on March 31, 2026
What is 1-year change in ELV quarterly EBITDA?
ELV quarterly EBITDA is down -16.15% year-over-year
How far is ELV quarterly EBITDA from its all-time high?
ELV quarterly EBITDA is currently -40.63% below its historical high of $4.48B set on December 31, 2009
How does ELV quarterly EBITDA rank versus sector peers?
ELV quarterly EBITDA is higher than 98.62% of companies in Healthcare sector
When is ELV next earnings release?
The next earnings release for ELV is on
TTM EBITDA
$7.74B$512.00M-6.20%
Summary
- Current Value
- As of today, ELV TTM EBITDA is $7.74B, down -6.20% on
- Historical Performance
- ELV TTM EBITDA is down -15.80% year-over-year, down -20.10% over the past 3 years
- All-Time High Comparison
- ELV TTM EBITDA is currently -23.30% below its historical high of $10.10B set on
- 3-Year Low Comparison
- ELV TTM EBITDA is at its 3-year low
- Sector Comparison
- ELV TTM EBITDA is higher than 98.16% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $7.74B | -6.2% | -15.8% | -20.1% | +3.4% | |
| Annual EBITDA | $8.26B | – | -11.2% | -11.0% | +11.7% | |
| Quarterly EBITDA | $2.66B | +328.0% | -16.1% | -13.7% | +8.1% | |
| Price | $372.68 | +9.4% | -9.1% | -18.4% | -4.8% | |
| PE Ratio | 15.86 | +17.0% | -0.9% | -12.4% | -24.3% | |
| TTM Revenue | $200.42B | +0.7% | +9.4% | +24.7% | +60.8% | |
| TTM EPS | $23.50 | -6.4% | -8.3% | -6.8% | +25.8% | |
| $6.22B | -7.3% | -19.9% | -21.4% | -1.7% | ||
| TTM Net Income | $5.24B | -7.5% | -11.3% | -14.3% | +11.1% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $9.20B | N/A | -15.8% |
| 3Y | $10.10B | -23.3% | |
| 5Y | $10.10B | -23.3% | |
| All | $10.10B | -23.3% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $7.74B | at low | |
| 3Y | $7.74B | at low | |
| 5Y | $6.72B | +15.3% | |
| All | $215.20M | +3498.5% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of ELV?
As of today, ELV TTM EBITDA is $7.74B
What is ELV TTM EBITDA most recent change?
ELV TTM EBITDA was down -6.20% on March 31, 2026
What is 1-year change in ELV TTM EBITDA?
ELV TTM EBITDA is down -15.80% year-over-year
How far is ELV TTM EBITDA from its all-time high?
ELV TTM EBITDA is currently -23.30% below its historical high of $10.10B set on June 30, 2024
How does ELV TTM EBITDA rank versus sector peers?
ELV TTM EBITDA is higher than 98.16% of companies in Healthcare sector
When is ELV next earnings release?
The next earnings release for ELV is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- ELV Official Website www.elevancehealth.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1156039/000115603926000006/0001156039-26-000006-index.htm
- ELV Profile on Yahoo Finance finance.yahoo.com/quote/ELV
- ELV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/elv